$PPBT Our finances were reconfirmed today with the new June 2021 Company Presentation, as well as directly addressed at Jefferies Healthcare Conference. Link: sec.report/Document/0001213... Strong Cash Runway, CM24 Pipeline Partner, & Reconfirmed Launch of Patented FDA-Approved Consensi in US, South Korea, and China with their respective distributing partners. The new NT219 data is strongly supported by our company's entirety, who's main objective is to capitalize heavily on novel NT219 potential while curing illness.
1
13
13 Likes